1. Cover
  2. Summary
  4. SeaBeLife enters into joint development agreement with Unither Pharmaceuticals to formulate and produce ophthalmic drug candidate27 pieces
  5. SeaBeLife secures €2 million69 pieces
  6. SeaBeLife achieves highly promising preclinical efficacy results for SBL0351 pieces
  7. News Coverage 20257 pieces

  10. Download report

    PDF

Next Section

SeaBeLife enters into joint development agreement with Unither Pharmaceuticals to formulate and produce ophthalmic drug candidate
Previous
Next

Spotify X